NCT00003657 - High-dose ICE With Amifostine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

November 30, 2000

Study Completion Date

June 30, 2002

Conditions

Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown PrimaryExtragonadal Germ Cell TumorHead and Neck CancerKidney CancerLung CancerOvarian CancerSarcomaTesticular Germ Cell TumorUnspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL

filgrastim

DRUG

Amifostine

DRUG

Carboplatin

DRUG

Etoposide

DRUG

Ifosfamide

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (3)

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Dana-Farber Cancer Institute, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER